echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > eLife Surprising Discovery: Epigenetic-Accelerated Aging Causes Bowel Cancer

    eLife Surprising Discovery: Epigenetic-Accelerated Aging Causes Bowel Cancer

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This study provides evidence that biological age may be one of the reasons for the increased risk of certain diseases, and paves the way for interventions to slow the process


    Epigenetic marks are changes in DNA that may change the way our genes work, changing as we age


    "When a person's biological age is older than their chronological age, they are said to be experiencing epigenetic age acceleration," explained first author Fernanda Morales-Bernstein.


    Establishing a causal relationship between biological clocks and disease is challenging because it is difficult to know whether biological aging increases the risk of disease, or whether other independent factors increase the risk of both disease and biological aging


    The team compared four established epigenetic clocks used to measure biological aging and their genetically predicted links to a range of cancer types


    They found limited evidence that epigenetic age acceleration is causally linked to breast, lung, ovarian or prostate cancer


    The most striking result was bowel cancer, measured with GrimAge, one of the second-generation clocks, showing that for every additional year of biological age (relative to chronological age), the risk of bowel cancer increased by 12 percent


    Previous studies have shown that epigenetic age acceleration is influenced by multiple cancer risk factors, such as obesity and smoking


    "Our work provides potentially relevant findings for public health," said senior author Rebecca Richmond, a Molecular Epidemiology Fellow at the University of Bristol Medical Research Council's Division of Integrative Epidemiology


    This research was conducted by: Wellcome; Cancer Research UK; Medical Research Council; Business Programme 'Competitiveness, Entrepreneurship and Innovation'; National Institutes of Health; NIH Biomedical Research Centre; Bristol and Weiss Dayton University Hospitals NHS Foundation Trust; Alzheimer's Society; National Institutes of Health

    Journal Reference :

    1. Fernanda Morales Berstein, Daniel L McCartney, Ake T Lu, Konstantinos K Tsilidis, Emmanouil Bouras, Philip C Haycock, Kimberley Burrows, Amanda I Phipps, Daniel D Buchanan, Iona Cheng, Richard M Martin, George Davey Smith, Caroline L Relton, Steve Horvath, Riccardo E Marioni, Tom G Richardson, Rebecca C Richmond.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.